Time: 2024-09-10
The NOTION-3 randomize test has shed light on the benefit of combining transcatheter aortal valve replacement ( TAVR ) with transdermal coronary_thrombosis intervention ( PCI ) for person with severe aortal stenosis and stable coronary_thrombosis artery disease ( CAD ) . consequence from the test , show at the European Society of Cardiology meeting , show a significant decrease in major adverse cardiac event at 2 old_age for patient who undergo both procedure compare to those who receive conservative treatment alone for CAD.
The findings bespeak a lower_berth hazard of myocardial infarct and pressing revascularization for patient who undergo attention_deficit_disorder - on PCI alongside TAVR . However , an addition in bleeding was note as a trade - murder for the improvement in result . The survey foreground the importance of individualize treatment decision establish on patient factor such as age , life anticipation , and overall health status.
A new randomize test has trip a argument among expert see the optimum timing of transdermal coronary_thrombosis intervention ( PCI ) before transcatheter aortal valve implantation ( TAVI ) in patient with severe aortal stenosis and stable coronary_thrombosis artery disease . The NOTION-3 survey uncover a decrease in major adverse cardiac event with PCI before TAVI , lead to discussion on whether revascularization should be the standard approach for all patient with significant CAD.
The argument also raise question about the timing and necessity of PCI in stable patient with severe aortal stenosis . While the NOTION-3 test show benefit of PCI before TAVI in reduction adverse event , expert foreground the need for foster evidence and bigger test to validate these findings . ongoing survey like the COMPLETE - TAVR test purpose to supply More penetration into the function of PCI in patient undergo TAVI.
Overall , the discussion surround the optimum management of cad in TAVR campaigner underscore the complexity of decision - devising in cardiology and the importance of individualize treatment scheme establish on patient feature and hazard factor . The evolve landscape of cardiovascular care continue to bring new challenge and opportunity for better patient result in the field of medicine.